home / stock / holx / holx news


HOLX News and Press, Hologic Inc. From 11/01/22

Stock Information

Company Name: Hologic Inc.
Stock Symbol: HOLX
Market: NASDAQ
Website: hologic.com

Menu

HOLX HOLX Quote HOLX Short HOLX News HOLX Articles HOLX Message Board
Get HOLX Alerts

News, Short Squeeze, Breakout and More Instantly...

HOLX - Hologic gains amid positive views from analysts on Q4 results

Hologic, Inc. ( NASDAQ: HOLX ) gained ~7% pre-market Tuesday as analysts issued favorable views on the COVID-19 test developer’s Q4 fiscal 2022 results that exceeded the company forecasts and the consensus. The company’s 2023 outlook which was in line w...

HOLX - Hologic, Inc. (HOLX) Q4 2022 Results - Earnings Call Transcript

Hologic, Inc. (HOLX) Q4 2022 Earnings Conference Call October 31, 2022 04:30 PM ET Company Participants Ryan Simon - VP, IR Stephen MacMillan - Chairman, President and CEO Karleen Oberton - CFO Conference Call Participants Patrick Donnelly - Citi ...

HOLX - Hologic gains on strong Q4 beat even after COVID driven contraction

The shares of Hologic, Inc. ( NASDAQ: HOLX ) spiked in the post-market trading Monday after the healthcare device maker said its financial measures for Q4 fiscal 2022 exceeded expectations even as the topline slumped amid pressure on COVID-19 testing and Breast Health business...

HOLX - Hologic Non-GAAP EPS of $0.82 beats by $0.20, revenue of $953.3M beats by $91.62M

Hologic press release ( NASDAQ: HOLX ): Q4 Non-GAAP EPS of $0.82 beats by $0.20 . Revenue of $953.3M (-27.8% Y/Y) beats by $91.62M . FY 2023 Guidance: Revenue expected between $3.7 - $3.9B vs. consensus of $3.87B; Non-GAAP EPS of $3.30 - $3.60 vs. consensus o...

HOLX - Hologic Announces Financial Results for Fourth Quarter of Fiscal 2022

– Revenue of $953 Million, GAAP Diluted EPS of $0.47, and Non-GAAP Diluted EPS of $0.82 All Exceed Expectations – – Global Organic Molecular Diagnostics Revenue Grows 17% in Constant Currency, ex-COVID-19 – – Fiscal 2023 Financial Guidance Anti...

HOLX - Hologic Q4 2022 Earnings Preview

Hologic ( NASDAQ: HOLX ) is scheduled to announce Q4 earnings results on Monday, October 31st, after market close. The consensus EPS Estimate is $0.62 (-61.5% Y/Y) and the consensus Revenue Estimate is $861.68M (-34.7% Y/Y). Over the last 2 years, HOLX has beaten EPS...

HOLX - Insulet: An Overpriced Play In The Medical Space

Summary Insulet Corporation has an interesting business model and management continues to grow the company's top line nicely. However, profits and cash flows have been showing signs of weakness and the stock looks very pricey at this time. Investors should be careful about thi...

HOLX - Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2022 on Monday, October 31, 2022

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the fourth quarter of fiscal 2022 on Monday, October 31, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Easter...

HOLX - Hologic Rings Nasdaq Opening Bell to Kick Off Breast Cancer Awareness Month

Tennis Legend Martina Navratilova Joins Hologic to Highlight Importance of Regular Screenings Hologic, Inc. Chairman, President and CEO Steve MacMillan will ring the Nasdaq opening bell today to mark the beginning of Breast Cancer Awareness Month. This is the 16 th t...

HOLX - Wall Street Breakfast: Goodbye TINA

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . For further details see: Wall Street Breakfast: Goodbye TINA

Previous 10 Next 10